Oral pain meds overtake injectable therapies as preferred treatment for multiple sclerosisOral therapies are revolutionizing the treatment paradigm of multiple sclerosis (MS), offering enhanced dosing and patient compliance, according to new analysis. Frost & Sullivan's A Product and Pipeline Analysis of...
which is associated with the pain and inflammation at the heart of OA.1Brunke addressed the concept of targeted therapy in a previously recorded episode ofdvm360® Live™,in which he said: “If you only have one arthritic joint, why are we giving systemic meds? While [they are] safe ...